Search Results - "Mikami, Tadayoshi"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Involvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain by YAMAMOTO, Watam, MIKAMI, Tadayoshi, IWAMURA, Hiroyuki

    Published in European journal of pharmacology (31-03-2008)
    “…We sought to examine the involvement of central cannabinoid CB2 receptor activation in modulating mechanical allodynia in a mouse model of neuropathic pain…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Contribution of Active and Inactive States of the Human 5-HT4d Receptor to the Functional Activities of 5-HT4–Receptor Agonists by Mikami, Tadayoshi, Sugimoto, Hiromi, Naganeo, Rie, Ohmi, Takashi, Saito, Toshiyuki, Eda, Hiroyuki

    “…In the present study, binding affinities of 5-hydroxytryptamine-4 (5-HT4) ligands for the human 5-HT4d receptor were determined using the agonist [3H]5-HT and…”
    Get full text
    Journal Article
  4. 4

    Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse by Araki, Tsutomu, Mikami, Tadayoshi, Tanji, Hiroaki, Matsubara, Mitsunobu, Imai, Yutaka, Mizugaki, Michinao, Itoyama, Yasuto

    “…We investigated neurochemically and neuropathologically the utility of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice as a model of…”
    Get full text
    Journal Article
  5. 5

    Pharmacological and clinical profile of inclisiran sodium, a long-acting LDL cholesterol lowering siRNA, LEQVIO for s.c. injection syringe 300 ‍mg by Mikami, Tadayoshi, Fujiwara, Yukari, Akahori, Mizuki, Tomimatsu, Naoko, Tamaki, Yuko

    Published in Nihon yakurigaku zasshi (01-07-2024)
    “…Inclisiran sodium (Brand name: LEQVIO for s.c. injection syringe 300 ‍mg, hereinafter referred to as inclisiran), a small interfering ribonucleic acid (siRNA)…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Involvement of central cannabinoid CB 2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain by Yamamoto, Wataru, Mikami, Tadayoshi, Iwamura, Hiroyuki

    Published in European journal of pharmacology (2008)
    “…We sought to examine the involvement of central cannabinoid CB 2 receptor activation in modulating mechanical allodynia in a mouse model of neuropathic pain…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    In vitro and in vivo pharmacological characterization of PF-01354082, a novel partial agonist selective for the 5-HT 4 receptor by Mikami, Tadayoshi, Komada, Tohru, Sugimoto, Hiromi, Suzuki, Keiko, Ohmi, Takashi, Kimura, Naoji, Naganeo, Rie, Nakata, Eriko, Nakatani, Keigo, Toga, Tetsuo, Eda, Hiroyuki, Sakakibara, Minoru

    Published in European journal of pharmacology (2009)
    “…The pharmacological profile of PF-01354082, a selective 5-HT 4 receptor partial agonist, was investigated. PF-01354082 displayed high affinity for human 5-HT…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    In vitro and in vivo pharmacological characterization of PF-01354082, a novel partial agonist selective for the 5-HT(4) receptor by Mikami, Tadayoshi, Komada, Tohru, Sugimoto, Hiromi, Suzuki, Keiko, Ohmi, Takashi, Kimura, Naoji, Naganeo, Rie, Nakata, Eriko, Nakatani, Keigo, Toga, Tetsuo, Eda, Hiroyuki, Sakakibara, Minoru

    Published in European journal of pharmacology (01-05-2009)
    “…The pharmacological profile of PF-01354082, a selective 5-HT(4) receptor partial agonist, was investigated. PF-01354082 displayed high affinity for human…”
    Get full text
    Journal Article
  14. 14
  15. 15